[Today's headlines]
The revised US Biosafety Act will be included in discussions without naming specific companies
According to the official website of the US House Rules Committee, etc., the revised US “Biosafety Act” has been incorporated into the latest version of the 2026 Defense Authorization Act, which stipulates that US federal agencies will be prohibited from signing contracts with “concerned biotechnology companies.” Unlike last year's multiple versions directly naming pharmaceutical companies such as Pharmaceutical and Kangde, this year's revised bill does not specifically name any companies, but stipulates that in the future, the White House Administration and Budget Office will draw up a list of restricted companies within one year after the bill is passed, referring to relevant lists from the US Department of Defense and others. The US House Rules Committee will meet on December 10 at 5 p.m. Beijing time to discuss the 2026 NDAA, which includes the bill.
[General outlook]
Hang Seng Index ADR rose 0.10%
Overnight, the US stock Dow Jones Industrial Average fell 179.03 points, or 0.38%, to close at 47560.29 points; the S&P 500 stock index fell 6.0 points to close at 6840.51 points, or 0.09%; and the Nasdaq Composite Index rose 30.59 points, to close at 23576.49 points, or 0.13%. Most of the big tech stocks rose, and Broadcom rose 1.29% to a record closing high. The precious metals and cryptocurrency sectors registered the highest gains, with Pan-American Silver rising by more than 11% and American Silver by more than 7%.
Most of the popular Chinese securities fell. Baidu fell more than 4%, while Xiaopeng Motors and Ideal Auto fell more than 3%. The Hang Seng Index ADR rose. On a proportional basis, it closed at 25458.69 points, up 24.46 or 0.10% from the Hong Kong closing.
According to Strategas Group's data, the implied fluctuation of the US stock market in either direction was slightly less than 1% after the Federal Reserve made its decision this Wednesday. A fluctuation of this magnitude would be the biggest one-day fluctuation in the benchmark stock index since March after the Federal Reserve's decision.
[Hot Topics Preview]
Trump says whether to cut interest rates immediately will be a litmus test for the new chairman of the Federal Reserve
US President Donald Trump has hinted that he will judge the performance based on whether the new chairman of the Federal Reserve immediately takes measures to cut interest rates. When asked in an interview with Politico if a quick interest rate cut would be a litmus test for the US Federal Reserve Chairman he personally chose, Trump answered “yes.” In an interview published Tuesday, Trump told Politico, “Yes. This person... should do the same. I don't think he's smart enough, and he doesn't like Trump.” Trump's remarks are an important signal to the new chairman of the Federal Reserve, showing his expectations for the new chairman to be nominated to lead the Federal Reserve.
Indonesia's crackdown on illegal mining operations, nickel companies bear the brunt
Indonesian President Prabowo Subianto's government is stepping up efforts to rectify the mining sector. The latest measure is to impose heavy fines on mining companies that operate illegally beyond the scope of forest permits. According to a new regulation issued by Indonesia's Ministry of Energy and Mineral Resources on December 1, companies will be fined between IDR 354 million and 6.5 billion for every hectare of forest land illegally occupied. The final fine will be determined based on the number of years of violation and the type of product being mined. Among them, nickel mining companies face the harshest penalties. The move is the latest action by the Prabowo government to crack down on illegal activities in the commodities sector. Previously, the government had sealed off several mining areas and millions of hectares of oil palm plantations and launched a corruption investigation against state-owned energy company PT Pertamina. The nickel ore involves Hong Kong stock Liqin Resources (02245) and Zhongwei New Materials (02579).
Hong Kong Real Estate: The three major real estate demand continues to enter the market, and Hong Kong property prices are expected to rise by about 10% in 2026
The Zhitong Finance App learned that Wang Pindi, director of the Hong Kong Real Estate Research Department, said that 2025 is a turning point for the Hong Kong property market. Driven by a number of favorable policies, market confidence has clearly recovered, property prices have stopped falling and rebounded, and the three major real estate demand support for self-occupation, rent collection, and investment marks a full return to market momentum. It is expected that the three major demands will continue to enter the market in 2026, driving property prices to rise by about 10% under optimistic conditions. Involves local real estate agents and real estate agents in Hong Kong.
People familiar with the matter: The total investment amount of all parties involved in the polysilicon collection and storage matter may be 20 billion yuan to 30 billion yuan
On December 9, it was reported that the “Polysilicon Production Capacity Integrated Acquisition Platform” was formally established. The company name is Beijing Guanghe Qiancheng Technology Co., Ltd., with a registered capital of 3 billion yuan. The date of establishment is December 9, 2025, and its residence is in Chaoyang District, Beijing. The picture of the business license attached to the news shows that the company's business scope includes technical services, technology development, technical consulting, technical exchange, technology transfer, technology promotion; enterprise management consulting. On November 6, the reporter learned from people close to the polysilicon collection and storage matter that the total investment amount of each party may be between 20 billion yuan and 30 billion yuan; the details are still uncertain. However, the total capital required to collect and store production capacity will be higher than this, and the exact amount is currently uncertain.
Chairman Peng Yongdong of Seashell-W (02423) sold shares to donate. This was the first time since listing that his holdings were reduced
On December 8, Shell US Stock issued an announcement. Peng Yongdong, co-founder, chairman and CEO of Shell, sold shares to fulfill previous donation promises. The sale is part of a previously announced donation plan. According to the announcement, 1400,000 ADS shares have been sold, which is equivalent to 4.2 million Class A common shares. According to reports, this is the first time that Peng Yongdong has sold shares since Shell's US stock listing in 2020, and all of them will be donated.
China Mobile: China Mobile Communications Group's holding ratio passively decreased to 68.9993%
China Mobile announced that as of November 30, 2025, the total number of shares of the company was 21,641 billion shares. Recently, due to the implementation of the company's Hong Kong stock options incentive plan, the total number of shares of the company increased to 21,641 billion shares. China Mobile Communications Group Co., Ltd. holds a total of 14.932 billion shares of the company, accounting for about 68.9993% of the company's total issued shares. Of these, it directly holds 42.367 million A-shares of the company and indirectly holds 14.89 billion shares of the company's common shares in Hong Kong through China Mobile Hong Kong Limited. The total holdings of China Mobile Communications Group Co., Ltd. passively decreased from 69.0022% to 68.9993% of the company's total issued shares, and the change in equity hit the 1% scale.
Degas Energy announced price increases for battery series products
On December 9, Degas Energy announced price adjustments for battery series products. The announcement said that due to the recent sharp rise in raw material prices for lithium batteries, battery production costs have increased. After careful research by the company, it was decided to adjust the sales price of battery series products: valid orders submitted and confirmed from now until December 15, 2025 will still be executed at the original price. Starting from December 16, 2025, the price of battery products will increase 15% from the current catalogue price. Degas Energy said that this price adjustment is to cope with short-term raw material cost fluctuations, and the price system will be dynamically optimized in the future according to market supply, demand, and cost changes. It involves the Hong Kong stock lithium battery sector.
Cyrus (09927) Zhang Xinghai: Ask the world that M8 sales exceeded expectations
On December 9, during Hongmeng Zhixing's annual live broadcast, Cyrus founder Zhang Xinghai said that the Wangjie M8, which went on sale this spring, has become the top 400,000 sales volume, far exceeding expectations, with pure electric sales accounting for more than one-third. According to the latest data, as of December 1, the cumulative delivery of the M8 exceeded 130,000 vehicles in the 7 months it went on sale, and 16,000 vehicles were delivered in November.
Geely Automobile (00175) Announces the Selection Results of Extreme Krypton Privatization Eligibility for Extreme Krypton Holders
On December 9, Geely Auto announced on the Hong Kong Stock Exchange to inform shareholders and potential investors about the latest developments in the selection results of eligible Krypton holders. The selection process has been completed, and the selection results are as follows: A total of 777,228,611 compensation shares will be allotted and issued to eligible extreme krypton holders who have made valid selections to receive compensation shares. (The number of shares to be issued is equivalent to the selection deadline) The total issued share capital of the company is approximately 7.7%; the Group will pay a total cash price of approximately US$701 million to the remaining eligible Krypton holders who have chosen or are deemed to have chosen to receive cash consideration. The company will apply to the Listing Committee for approval to list and trade 777,228,611 consideration shares.
Botai Auto Federation (02889) was selected by a leading OEM NEV company as the supplier for next-generation smart car cockpit projects
Zhitong Finance App News, Botai Auto Federation (02889) announced that the company received a project fixed notice from a leading OEM NEV company (the customer), and the company was selected by the customer as the supplier for the next-generation smart car cockpit project. The project service is also based on the new model 8397 platform. As Qualcomm's fifth-generation cockpit computing platform, the 8397 provides advanced AI capabilities, excellent computing performance, and high-definition graphics functions to help the large end-side AI model operate at higher performance, and is committed to providing smart cockpit solutions with high performance, high scalability and safety.
Fosun Pharmaceuticals (02196): Subsidiaries Pharmaceuticals, Fosun Pharmaceutical Industries and Pfizer jointly signed a “License Agreement”
Zhitong Finance App News, Fosun Pharmaceuticals (02196) issued an announcement. On December 9, 2025, the company's holding subsidiaries, Yakyu Pharmaceuticals, Fosun Pharmaceutical Industry, and Pfizer jointly signed a “License Agreement”. (This mainly includes) Pharmacopharmaceuticals grants Pfizer the exclusive development, use, production and commercialization rights for oral small molecule glucagon-like peptide-1 receptor (including YP05002) agonists (including YP05002) and products containing this active ingredient in the licensed region (that is, worldwide) and fields (treatment, diagnosis and prevention of all indications in humans and animals); just GLP-1R Under this license, Yaoyou Pharmaceutical will be entitled to receive (including) a non-refundable down payment of 150 million US dollars and development milestone payments of up to 350 million US dollars based on clinical and commercialization progress of the licensed product.
Quanxin Bio-B (02509): QX030N obtained approval from the Human Research Ethics Committee for phase I clinical trial in Australia and received milestone payment
According to the Zhitong Finance App, Quanxin Bio-B (02509) announced that on December 8, 2025, the company received a milestone payment of 5 million US dollars from partner Caldera Therapeutics, Inc. (Caldera). The payment was triggered by QX030N/CLD-423* obtaining an ethics license from the Human Research Ethics Committee (HREC) Phase I clinical trial ethics committee (HREC).
Baoji Pharmaceutical-B (02659) closed the dark market surged more than 114%
The Zhitong Finance App learned that on December 9, Baoji Pharmaceutical-B (02659) undercover trading showed tremendous gains, and market sentiment was high. By the close, undercover trading showed a price of HK$56.5, up 114.18% from the offer price of HK$26.38. The increase was further expanded from the opening. Each lot earned HK$3012, with 100 shares per lot without handling fees. Baoji Pharmaceutical will be listed on December 10, with CITIC Securities and Cathay Pacific Haitong as co-sponsors.
[Individual stock prices are clear]
Bolton, China (03318): Land acquisition agreement with local authorities in Nanshan District of Shenzhen received cash compensation of 2,272 billion yuan and resumed trading on December 10
According to Zhitong Finance App, China's Bolton (03318) announced that on December 7, 2025, Shenzhen Bolton (an indirect wholly-owned subsidiary of the Company) signed a land acquisition agreement with the local department. Shenzhen Bolton shall hand over the proposed land and land use rights to the local department in exchange for cash compensation of RMB 2,271,913,552 (equivalent to approximately HK$2,495,015,463).